Proteomics has scored a major US win, with Medicare setting a US$390.75 reimbursement price for its predictive kidney disease blood test, clearing the path for nationwide clinical uptake.
Business / Companies
Brisbane Times – Business
Proteomics has scored a major US win, with Medicare setting a US$390.75 reimbursement price for its predictive kidney disease blood test, clearing the path for nationwide clinical uptake.
Business / Companies
Brisbane Times – Business